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Impact on contraceptive practice of making emergency hormonal
contraception available over the counter in Great Britain: repeated
cross sectional surveys
Cicely Marston, Howard Meltzer, Azeem Majeed
Abstract
Objective To examine the impact on contraceptive practice of
making emergency hormonal contraception available over the
counter.
Design Analysis of data on contraceptive practice for women
aged 16-49 years in the period 2000-2 from the Omnibus
Survey, a multipurpose survey in which around 7600 adults
living in private households are interviewed each year.
Setting Private households in Great Britain.
Main outcome measures Use of different types of
contraception and rates of unprotected sex.
Results After emergency hormonal contraception was made
available over the counter, levels of use of different types of
contraception by women aged 16-49 remained similar. No
significant change occurred in the proportion of women using
emergency hormonal contraception (8.4% in 2000, 7.9% in
2001, 7.2% in 2002) or having unprotected sex. A change did,
however, occur in where women obtained emergency hormonal
contraception; a smaller proportion of women obtained
emergency hormonal contraception from physicians and a
greater proportion bought it over the counter. No significant
change occurred in the proportion of women using more
reliable methods of contraception, such as the oral
contraceptive pill, or in the proportion of women using
emergency hormonal contraception more than once during a
year.
Conclusions Making emergency hormonal contraception
available over the counter does not seem to have led to an
increase in its use, to an increase in unprotected sex, or to a
decrease in the use of more reliable methods of contraception.
Introduction
In May 2004, the US Food and Drug Administration (FDA) went
against the advice of its own scientific experts and blocked an
application for non-prescription sales of emergency hormonal
contraception (EHC).1 The decision was controversial: the FDA
was accused of making its decision on political rather than scien-
tific grounds.2 3 In the United States and elsewhere, debate about
making EHC available over the counter has centred not on the
safety of the drug itself—its safety is well documented4 5—but on
the harmful effects some people claim it will have on women’s
behaviour. In particular, opponents say that over the counter
availability will encourage unprotected sex, increase “abuse” of
EHC (“abuse” seeming to mean multiple uses over a limited time
period),6 undermine the use of more reliable methods of contra-
ception,7 and lead to increased promiscuity and pregnancy
among teenagers.8 On the other hand, people in favour of mak-
ing EHC available over the counter argue that easier access to it
will help to reduce unwanted pregnancies.9
This debate, although heated, has been based largely on
speculation. Small studies have strongly suggested that easier
availability does not lead to “abuse” of EHC.10–13 The wider popu-
lation effects are not known, however, because no large studies
have compared patterns of use of EHC before and after the ban
on over the counter sales has been lifted. We do not therefore
know whether relaxing controls on over the counter EHC leads
to an increase in its use.
An overall increase in use could support either argument. It
could indicate that more people were having unsafe sex, or more
frequent unsafe sex, knowing they would be able to obtain EHC
easily afterwards. Ease of access might also encourage women
using other forms of contraception to switch to EHC. An
increase in use could also indicate that EHC was being used
more often after episodes of unprotected sex that would have
occurred anyway. This could happen simply because EHC
became easier to obtain for women who might have been unwill-
ing to go to a physician. Such an increase might therefore lead to
fewer unwanted pregnancies,
Since January 2001 EHC has been available without
prescription across Britain to women aged 16 or over at a cost of
£20-25 ($36-46; €30-38).9 14 There was considerable opposition
to the change, including an unsuccessful post hoc challenge to
the legality of over the counter provision.15 EHC remains
available on prescription at no cost from various sources, includ-
ing general practitioners, family planning clinics, and hospitals.
Three surveys of contraceptive use in a representative sample
of the British population were carried out between 2000 and
2002: the year before introduction of over the counter provision
of EHC and the two subsequent years. We used these survey data
to examine use of EHC among British women aged 16 to 49
years to assess the impact of making EHC available over the
counter.
Methods
Data were collected in the Omnibus Survey, a multipurpose sur-
vey carried out by the UK Office for National Statistics. Approxi-
mately 1900 adults (aged 16 or over) living in private households
in Great Britain are recruited each month for four non-
consecutive months each year. People are sampled once each,
leading to an annual total of around 7600. This paper reports
results from the contraception module of the Omnibus Survey,
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carried out each year between June and the following March. For
simplicity, dates given in this paper are truncated; for example,
2000 refers to the period June 2000 to March 2001. Over the
counter EHC became widely available in February 2001. The
end of the 2000 survey therefore overlapped slightly with its
introduction.
In 2000, 2001, and 2002 the contraceptive module
comprised interviews with 6747, 7211, and 7638 adults. The
Omnibus Survey uses the postcode address file of “small users”
as its sampling frame. All private household addresses in Great
Britain are included in this frame. A new sample of 100 postal
sectors is selected each month and is stratified by region, the
proportion of households renting from local authorities, and the
proportion in which the head of household is a professional, an
employer, or a manager. Around 9900 postal sectors exist in the
United Kingdom, corresponding to all but the last part of the
postcode; in the postcode PO16 7DZ, for instance, the postal
sector would be indicated by PO16 7. Sectors are selected with
probability proportionate to size, and 30 addresses are selected
randomly from within each sector. If an address contains more
than one household, the interviewer uses a standard ONS proce-
dure to select one household at random. In households with
more than one adult member, one person aged 16 or over is
selected through the use of random number tables. The
interviewers try to interview that person: proxy interviews are
not taken.
Weighting factors are applied to Omnibus data to correct for
unequal probability of selection caused by interviewing only one
eligible adult per household. The weighting does not attempt to
correct for any non-response bias. Further information is
available in the survey reports.16–18 The proportion of eligible
women answering relevant questions for this study was 97% in
2000 (n = 1864 unweighted, n = 1978 weighted), 96% in 2001
(n = 1999 unweighted, n = 2078 weighted), and 96% in 2002
(n = 2121 unweighted, n = 2202 weighted).
The survey asked women questions about their contraceptive
use and included specific questions about EHC. Demographic
details were also collected; for this analysis we used age,
education level, de facto marital status, and income. We divided
income into three categories as near as possible to the 33rd and
the 67th centiles and assigned women to “high,” “middle,” and
“low” income groups in similar numbers. We examined two
binary outcome variables: use or non-use of EHC in the previous
year and, for the subsample of EHC users, whether or not EHC
was bought over the counter. Univariate analyses used 2 tests,
and multivariate analysis used logistic regression models.We first
did the multivariate analyses for each year separately. We then
combined the data from each survey year and added survey year
as a dummy variable to test for differences between years.
Because we found no significant difference between the years,
and results from the combined dataset were similar to those
obtained from each survey separately, we present the results for
the combined datasets here.
Results
The level of use of different contraceptives by British women
aged 16-49 remained very similar before and after EHC was
made available over the counter (table 1). No significant changes
occurred in the proportions of women reporting current use of
any of the methods over time. The proportion of women who
said they used condoms “whenever I have sexual intercourse”
was similar in 2000 and 2002 but dipped in 2001 (2000 = 59%,
2001 = 52%, 2002 = 60%; P = 0.04). When these women were
grouped together with those who said that they “usually” used
condoms, the proportion using condoms did not change signifi-
cantly (2000 = 75%, 2001 = 73%, 2002 = 73%; P = 0.70).
One striking development was the change in where women
obtained EHC (table 2). The proportion of women reporting
that they obtained it from pharmacies increased to a third, and
the proportion who said they obtained it from other sources fell.
Yet overall use of EHC remained the same, and no significant
change occurred in the very small proportion of women report-
ing two or more uses of EHC in a year (table 3).
Tables 4 and 5 show the characteristics of the women who
said they had used EHC and the subgroup of women who said
they had bought it over the counter. Table 4 shows that in the
univariate analysis age, marital status, and education were signifi-
cantly associated with use of EHC. Younger, single women were
most likely to report having used it, with highest use among
20-24 year olds in 2000 and 2002 and among 16-19 year olds in
Table 1 Current use of contraception reported by women aged 16-49 in
Great Britain, by year
Contraception
Proportion (%) of women reporting current
use
2000 2001 2002
Current method:
Oral contraceptive, intrauterine device,
injections, implants
31.8 33.7 31.9
Condom, cap, diaphragm 21.0 20.5 20.0
Withdrawal/rhythm method 3.9 4.7 3.7
Other method 1.2 1.0 0.8
Woman or partner sterilised 24.8 24.7 24.3
No method:
No heterosexual relationship 12.4 12.0 14.0
Other reasons (including abstinence) 10.6 8.6 8.0
Base (unweighted)* 1931 2084 2221
*Percentages add up to more than 100 because women could give more than one answer.
Table 2 Sources of emergency hormonal contraception reported by women
aged 16-49 in Great Britain, by year
Source
Proportion (%) of women obtaining EHC from source*
2000 2001 2002
General practitioner 62.0 51.2 48.8
Family planning clinic 33.0 31.1 18.2
Hospital emergency department 3.2 2.0 4.6
Pharmacy† NA 19.7 32.6
Walk in/minor injuries unit† NA 1.2 0.4
Elsewhere 5.2 1.6 3.7
Base (unweighted) 130 129 135
NA=not applicable.
*Percentages add up to more than 100 because women could report more than one source if
they had used emergency hormonal contraception more than once.
†Not included in 2000 survey.
Table 3 Number of times emergency hormonal contraception used per year
reported by British women aged 16-49
Emergency hormonal contraception
Proportion (%) of women reporting use
2000 2001 2002
No of times used in year:
Once 6.5 6.3 5.6
Twice or more 2.0 1.5 1.7
Not used 91.6 92.2 92.8
Total 100.0 100.0 100.0
Base (unweighted)* 1503 1659 1747
*Excludes women sterilised at least two years ago. Women not answering “yes” to question
“have you heard of the pill method of emergency contraception after intercourse” also
excluded (n=129 in 2000, n=115 in 2001, n=113 in 2002; no significant change over time).
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2001. In 2001, but not in the other years, fewer women with a
degree or other higher education qualification reported using
EHC, compared with other women. Little change in use
occurred over time, although among 16-19 year olds a small,
non-significant rise in use in 2000-1 was followed by a significant
drop between 2001 (2 = 1.54, P = 0.24) and 2002 (2 = 7.11,
P = 0.01).
The multivariate analysis (table 5) shows that the factors
explaining EHC use did not change significantly over time. The
only significant predictors of EHC use were marital status and
age. Single women were nearly three times as likely to report
EHC use as married women. Younger women were more likely
to report EHC use: women aged 20-24 were nearly three times
as likely to report use of EHC compared with women aged over
30, and teenage women were just over twice as likely to report
use of EHC as women over 30. However, in terms of absolute
numbers, more than half of users of EHC were over 25 (53%
over the three year period). Neither income nor education was
significantly related to likelihood of using EHC.
Most of the subgroup who said they bought EHC over the
counter were over 25 years old. The univariate analysis (table 4)
showed that those who bought EHC were also significantly more
likely to come from the higher income groups and, in 2001, from
higher age groups. Between 2001 and 2002 no significant
change occurred in any subgroup in proportions of women buy-
ing EHC over the counter (not shown).
Table 5 shows the adjusted odds ratios for buying EHC over
the counter once this option became available (2001-2). Obtain-
ing EHC without prescription was not associated with age or
marital status. After adjustment for the other variables, however,
income remained highly significant: higher income women were
more than five times as likely to report obtaining EHC without
prescription as lower income women. Once income was taken
into account, the other variables had no significant effect on
whether or not EHC was bought over the counter.
Discussion
Allowing emergency hormonal contraception to be sold over the
counter in the United Kingdom has not increased its use or
changed patterns of use. Not only has use remained stable, but
predictors of use—age and marital status—have remained
constant and are entirely different from the sole predictor of
whether or not EHC is obtained over the counter—income. This
suggests that use of EHC is not affected by its being made avail-
able over the counter.
Opponents of lifting the ban on over the counter sales say
that easier access will lead to “abuse” of EHC and will encourage
unsafe sex, particularly among teenagers. Our study provides no
evidence to support this argument, although the sample of teen-
age women is relatively small. The proportion of women using
Table 4 Proportion of British women aged 16-49 who used emergency hormonal contraception (EHC), 2000-2, and proportion who bought EHC over the
counter in 2001 and 2002: by age group, marital status, education, and annual income
Proportion (%) of women reporting use of EHC
Proportion (%) of women using EHC obtaining EHC
without prescription
2000 2001 2002 2001 2002
Age group (years):
16-19 15.3 21.5* 8.9† 5.2 16.7
20-24 17.3 12.0 19.7 18.4 21.1
25-29 10.0 9.5 12.7 27.3 34.5
30-34 8.2 7.0 7.0 47.6 25.6
≥35 3.8 3.0 2.1 11.9 62.5
2 (column) 48.8 77.4 91.3 17.4 10.0
P value 0.0000 0.0000 0.0000 0.0129 0.0800
De facto marital status:
Married 3.2 2.3 3.4 29.4 44.4
Cohabiting 8.9 8.3 9.3 21.1 28.6
Single 15.7 14.4 12.3 14.1 27.6
Other‡ 10.3 11.2 7.7 33.3 39.1
2 (column) 57.2 65.0 40.0 4.5 3.1
P value 0.0000 0.0000 0.0000 0.2680 0.3918
Education level:
Degree or other higher qualification 6.5 5.6 7.7 19.2 40.0
Secondary/none/other qualifications 9.3 8.8 7.0 19.8 29.3
Missing cases 3 1 2 0 0
2 (column) 3.2 4.8 0.2 0.0 1.5
P value 0.0949 0.0376 0.6563 0.9448 0.2834
Annual income (£):
<6240 10.5 9.0 8.7 11.7 15.3
6240-15 599 6.5 8.1 6.5 17.2 31.1
≥15 600 6.6 6.1 6.9 44.0 56.1
Missing cases 104 104 85 4 2
2 (column) 7.2 2.8 2.3 11.3 17.0
P value 0.0420 0.3131 0.3576 0.0207 0.0014
Base (unweighted)§ 1701 1859 1984 129 135
*Non-significant rise from 2000 (2=1.54, P=0.24).
†Significant drop from 2001 (2=7.11, P=0.01).
‡Widowed, divorced, separated, same sex cohabiting.
§Excludes women sterilised at least two years before.
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EHC remained stable after the ban was lifted, and no changes
occurred in the characteristics of women using it.
However, this study also offers little support to those who
argue that easier access to EHC may help to prevent unwanted
pregnancies.19 Women did not report more use of the method
once it was made available over the counter: they seem simply to
have changed where they obtained it. This finding is supported
by a small British study of two hospital emergency departments,
which showed that requests for EHC fell after it was made avail-
able over the counter.20 Over the counter availability is therefore
unlikely to have affected unwanted pregnancies.
The sharp rise in the proportion of women buying EHC over
the counter indicates that many women prefer this way of
obtaining it. Easier access may also have meant that women
obtained it faster, and hence were able to take it within the
recommended 72 hours after unprotected sex.21 The survey did
not measure this, however, and this is an area for further
research.
This study is the first national survey of EHC use from any
country that examines the impact of lifting the ban on over the
counter sales. It has some weaknesses, however. Firstly, because
there were relatively few respondents from non-white ethnic
groups, we could not break down EHC use by ethnicity.
Secondly, relatively few women used EHC, or bought it over the
counter, which limits the power of the study to detect small
changes. Thirdly, no women under 16 years old were included,
although at present they are not permitted to buy EHC from
pharmacies. Fourthly, factors not examined in this study could
have been responsible for keeping use of EHC steady when it
became available over the counter. For instance, people might
have become more likely to use EHC after any given sexual
encounter but the total number of sexual encounters might have
fallen—that is, sexual activity in the population decreased—
although on current evidence this seems unlikely.22 23
Our study has important policy implications. The main
lessons from Great Britain in making EHC available over the
counter are that, firstly, many women seem to prefer obtaining
EHC this way rather than from a physician: uptake has been
high, with corresponding savings in time and resources for the
health service. Secondly, cost seems to be an important barrier to
buying EHC over the counter—lowering the cost might increase
uptake from this source, particularly in lower income groups.
Thirdly, lifting the ban in the UK did not lead to any increase in
the proportion of women using EHC, nor did it raise the
proportion of women using EHC more than once during a year.
Finally, no fall occurred in the use of more reliable methods of
contraception.
Although the lack of any increase in use of EHC suggests that
the predicted rise in unsafe sex has been overstated, so too have
been the predicted effects on unwanted pregnancy. However,
given the apparent absence of negative consequences, and the
fact that many women clearly prefer to buy EHC over the coun-
ter, our study supports the case for lifting the ban on over the
counter sales of EHC in the United States and other countries.
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